DOI: 10.1007/978-3-7091-0579-5_14. The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease

The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease

10.1007/978-3-7091-0579-5_14

Crossref book-chapter

Springer Vienna

Journal of Neural Transmission. Supplementa (297)

Bibliography

Beister, A., Kraus, P., Kuhn, W., Dose, M., Weindl, A., & Gerlach, M. (2004). The N-methyl-D-aspartate antagonist memantine retards progression of Huntingtonâs disease. Focus on Extrapyramidal Dysfunction, 117â122.

Authors 6

A. Beister (first)
P. Kraus (additional)
W. Kuhn (additional)
M. Dose (additional)
A. Weindl (additional)
M. Gerlach (additional)

References 19 Referenced 64

Beal MF (1995) Ageing, energy and oxidative stress in neurode generative diseases. Ann Neurol 38: 357–366 (10.1002/ana.410380304) / Ann Neurol by M Beal (1995)
Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteris tics of Huntington’s disease by quinolinic acid. Nature 321: 29–38 (10.1038/321168a0) / Nature by MF Beal (1986)
Bylsma FW, Rothlind J, Hall MR, Folstein SE, Brandt J (1993) Assessment of adapt ive functioning in Huntington’s disease. Mov Disord 8: 183–190 (10.1002/mds.870080212) / Mov Disord by FW Bylsma (1993)
Ehle AL, Stewart RM, Lellied NA, Leventhal NA ( 1984) Evoked potentials in Huntington’s disease. Arch Neurol 41: 379–382 (10.1001/archneur.1984.04050160041013) / Arch Neurol by AL Ehle (1984)
Erzigkeit H (1992) SKT: Ein Kurztest zur Erfassung von Gedächtnis-und Aufmerksamkeit sstorungen, Beltz Test Weinheim / SKT: Ein Kurztest zur Erfassung von Gedächtnis-und Aufmerksamkeit sstorungen by H Erzigkeit (1992)
Gerlach M, Riederer P, Youdim MBH (1996 ) Molecul ar mechanisms for neurodegeneration: synergism between reactive oxygen species, calcium and excitotoxic amino acids. Adv Neurol 169: 177–194 / Adv Neurol by M Gerlach (1996)
Guy W ( 1976) ECDEU. Assessment manual for psychopharmacology, revised edn. US Department of Health, Education and Welfare Washington DC / ECDEU. Assessment manual for psychopharmacology by W Guy (1976)
Huntington Study Group (1996) Unified Huntington’s disease rating scale. Reliability and consistency. Mov Disord 11: 136–142 (10.1002/mds.870110204) / Mov Disord by Huntington Study Group (1996)
Jellinger KA (2003) General aspects of neurodegeneration. J Neural Transm [Suppl] 65: 101–144 (10.1007/978-3-7091-0643-3_7) / J Neural Transm [Suppl] by K Jellinger (2003)
Kieburtz K, Koroshetz W, McDermott M, Beal MF, Greenamyre JT, Ross CA, Shoulson I, Cudkowicz ME, Sexton P, Skeuse C, Rosas D, Jenkins B, Rosenblatt A, Sherr M, Hersch S, Cell ar J, Guttman M, Brown C, Como PG, Marshall F, DeMarcaida JA, Zimmerman C, Marder K, Moskowitz C, Polanco C, Beltre J, Shannon K, Jaglin JA, Niederman F, Ashizawa T, Hunter C, Hauser R, Walker A, Gauger L, Hahn MA, Delgado H, Dawson T, Siemers E, Seeberger L, Dingmann C, Dubinsky R, Gray C, Weiner WJ, Rodriguez-Batemen D, Albin RL, Wernette K, Harrison M, Rost-Ruffner E, Paulsen J, Rodnitzky RL, Dobson J, Vining L, Suchowersky O, Pantella C, Saint-Hilaire MH, Furtado J, Martin W, Wieler M, Walker F, Hunt V, Raymond L, Almqvist E, Rubin A, Blair B, Marek K, Caplan K, Baker D, Brocht A, Casaceli C, Orme C, Rudolph A, Rumfola L, Schifitto G, Shinaman A, Sulimowicz K, Watts A, Eapen S, Zhang L, The Huntington Study Group (2001) A randomized, placebocontrolled trial of coenzyme Q(10) and remacemide in Huntington’s disease. Neurology 57: 397–404 / Neurology by K Kieburtz (2001)
Kremer B, Clark CM, Almqvist EW, Raymond LA, Graf P, Jacova C, Mezei M, Hardy MA, Snow B, Martin W, Hayden MR (1999) Influence of lamotrigine on progression of early Huntington disease — a randomized clinical trial. Neurology 53: 1000–1011 (10.1212/WNL.53.5.1000) / Neurology by B Kremer (1999)
Lange HW (1983) Quantitative changes of telencephalon, diencephalon and mesencephalon in Huntington’s chorea, postencephalitic and idiopathic parkinsonism. Verh Anat Ges 75: 923–925 / Verh Anat Ges by H Lange (1983)
Lehrl S, Gallwitz A, Blaha L, Fischer B (1980) Kurztest für allgemein e Intelligenz KAI. VLESS Vaterstetten / Kurztest für allgemein e Intelligenz KA by S Lehrl (1980)
MacDonald ME, Gusella JF (1996) Huntington’s disease: translating a CAG repeat into a pathogenic mechanism. Cuff Opin Neurobiol 6: 638–643 (10.1016/S0959-4388(96)80097-3) / Cuff Opin Neurobiol by ME MacDonald (1996)
Murman DL, Giordani B, Mellow AM, Johanns JR, Little RJA, Hariharan M, Foster NL (1997) Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington’s disease. Neurology 49: 153–161 (10.1212/WNL.49.1.153) / Neurology by DL Murman (1997)
Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated NMDA receptor antagonist-a review of preclinical data. Neuropharmacology 138: 735–767 (10.1016/S0028-3908(99)00019-2) / Neuropharmacology by CG Parsons (1999)
Pellegrini JW, Lipton SA (1993) Delayed administration of memantine prevents N-methyl-Daspartate receptor mediated neurotoxicity. Ann Neurol 33: 403–407 (10.1002/ana.410330414) / Ann Neurol by JW Pellegrini (1993)
Raitan RM (1956) Trail Making Test. Manual for administration, scoring and interpolation. Indiana University Press Indianapolis
Shoulson I, Fahn S (1979) Huntington disease; clinical care and evaluation. Neurology 29: 1–3 (10.1212/WNL.29.1.1) / Neurology by I Shoulson (1979)

Dates

Type	When
Created	12 years, 11 months ago (Oct. 1, 2012, 1:54 a.m.)
Deposited	6 years, 3 months ago (May 16, 2019, 12:25 a.m.)
Indexed	1 week, 4 days ago (Aug. 21, 2025, 1:10 p.m.)
Issued	21 years, 8 months ago (Jan. 1, 2004)
Published	21 years, 8 months ago (Jan. 1, 2004)
Published Print	21 years, 8 months ago (Jan. 1, 2004)

Funders 0

None

BibTeX

@inbook{Beister_2004, title={The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease}, ISBN={9783709105795}, ISSN={0303-6995}, url={http://dx.doi.org/10.1007/978-3-7091-0579-5_14}, DOI={10.1007/978-3-7091-0579-5_14}, booktitle={Focus on Extrapyramidal Dysfunction}, publisher={Springer Vienna}, author={Beister, A. and Kraus, P. and Kuhn, W. and Dose, M. and Weindl, A. and Gerlach, M.}, year={2004}, pages={117–122} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        21
      ]
    ],
    "date-time": "2025-08-21T17:10:48Z",
    "timestamp": 1755796248029
  },
  "publisher-location": "Vienna",
  "reference-count": 19,
  "publisher": "Springer Vienna",
  "isbn-type": [
    {
      "type": "print",
      "value": "9783211211144"
    },
    {
      "type": "electronic",
      "value": "9783709105795"
    }
  ],
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2004,
            1,
            1
          ]
        ],
        "date-time": "2004-01-01T00:00:00Z",
        "timestamp": 1072915200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2004
      ]
    ]
  },
  "DOI": "10.1007/978-3-7091-0579-5_14",
  "type": "book-chapter",
  "created": {
    "date-parts": [
      [
        2012,
        10,
        1
      ]
    ],
    "date-time": "2012-10-01T05:54:21Z",
    "timestamp": 1349070861000
  },
  "page": "117-122",
  "source": "Crossref",
  "is-referenced-by-count": 64,
  "title": "The N-methyl-D-aspartate antagonist memantine retards progression of Huntington\u2019s disease",
  "prefix": "10.1007",
  "author": [
    {
      "given": "A.",
      "family": "Beister",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "P.",
      "family": "Kraus",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "W.",
      "family": "Kuhn",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "M.",
      "family": "Dose",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "A.",
      "family": "Weindl",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "M.",
      "family": "Gerlach",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "14_CR1",
      "doi-asserted-by": "publisher",
      "first-page": "357",
      "DOI": "10.1002/ana.410380304",
      "volume": "38",
      "author": "M Beal",
      "year": "1995",
      "unstructured": "Beal MF (1995) Ageing, energy and oxidative stress in neurode generative diseases. Ann Neurol 38: 357\u2013366",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "14_CR2",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "DOI": "10.1038/321168a0",
      "volume": "321",
      "author": "MF Beal",
      "year": "1986",
      "unstructured": "Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteris tics of Huntington\u2019s disease by quinolinic acid. Nature 321: 29\u201338",
      "journal-title": "Nature"
    },
    {
      "key": "14_CR3",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "DOI": "10.1002/mds.870080212",
      "volume": "8",
      "author": "FW Bylsma",
      "year": "1993",
      "unstructured": "Bylsma FW, Rothlind J, Hall MR, Folstein SE, Brandt J (1993) Assessment of adapt ive functioning in Huntington\u2019s disease. Mov Disord 8: 183\u2013190",
      "journal-title": "Mov Disord"
    },
    {
      "key": "14_CR4",
      "doi-asserted-by": "publisher",
      "first-page": "379",
      "DOI": "10.1001/archneur.1984.04050160041013",
      "volume": "41",
      "author": "AL Ehle",
      "year": "1984",
      "unstructured": "Ehle AL, Stewart RM, Lellied NA, Leventhal NA ( 1984) Evoked potentials in Huntington\u2019s disease. Arch Neurol 41: 379\u2013382",
      "journal-title": "Arch Neurol"
    },
    {
      "key": "14_CR5",
      "volume-title": "SKT: Ein Kurztest zur Erfassung von Ged\u00e4chtnis-und Aufmerksamkeit sstorungen",
      "author": "H Erzigkeit",
      "year": "1992",
      "unstructured": "Erzigkeit H (1992) SKT: Ein Kurztest zur Erfassung von Ged\u00e4chtnis-und Aufmerksamkeit sstorungen, Beltz Test Weinheim"
    },
    {
      "key": "14_CR6",
      "first-page": "177",
      "volume": "169",
      "author": "M Gerlach",
      "year": "1996",
      "unstructured": "Gerlach M, Riederer P, Youdim MBH (1996 ) Molecul ar mechanisms for neurodegeneration: synergism between reactive oxygen species, calcium and excitotoxic amino acids. Adv Neurol 169: 177\u2013194",
      "journal-title": "Adv Neurol"
    },
    {
      "key": "14_CR7",
      "volume-title": "ECDEU. Assessment manual for psychopharmacology",
      "author": "W Guy",
      "year": "1976",
      "unstructured": "Guy W ( 1976) ECDEU. Assessment manual for psychopharmacology, revised edn. US Department of Health, Education and Welfare Washington DC",
      "edition": "revised edn."
    },
    {
      "key": "14_CR8",
      "doi-asserted-by": "crossref",
      "first-page": "136",
      "DOI": "10.1002/mds.870110204",
      "volume": "11",
      "author": "Huntington Study Group",
      "year": "1996",
      "unstructured": "Huntington Study Group (1996) Unified Huntington\u2019s disease rating scale. Reliability and consistency. Mov Disord 11: 136\u2013142",
      "journal-title": "Mov Disord"
    },
    {
      "key": "14_CR9",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "DOI": "10.1007/978-3-7091-0643-3_7",
      "volume": "65",
      "author": "K Jellinger",
      "year": "2003",
      "unstructured": "Jellinger KA (2003) General aspects of neurodegeneration. J Neural Transm [Suppl] 65: 101\u2013144",
      "journal-title": "J Neural Transm [Suppl]"
    },
    {
      "key": "14_CR10",
      "first-page": "397",
      "volume": "57",
      "author": "K Kieburtz",
      "year": "2001",
      "unstructured": "Kieburtz K, Koroshetz W, McDermott M, Beal MF, Greenamyre JT, Ross CA, Shoulson I, Cudkowicz ME, Sexton P, Skeuse C, Rosas D, Jenkins B, Rosenblatt A, Sherr M, Hersch S, Cell ar J, Guttman M, Brown C, Como PG, Marshall F, DeMarcaida JA, Zimmerman C, Marder K, Moskowitz C, Polanco C, Beltre J, Shannon K, Jaglin JA, Niederman F, Ashizawa T, Hunter C, Hauser R, Walker A, Gauger L, Hahn MA, Delgado H, Dawson T, Siemers E, Seeberger L, Dingmann C, Dubinsky R, Gray C, Weiner WJ, Rodriguez-Batemen D, Albin RL, Wernette K, Harrison M, Rost-Ruffner E, Paulsen J, Rodnitzky RL, Dobson J, Vining L, Suchowersky O, Pantella C, Saint-Hilaire MH, Furtado J, Martin W, Wieler M, Walker F, Hunt V, Raymond L, Almqvist E, Rubin A, Blair B, Marek K, Caplan K, Baker D, Brocht A, Casaceli C, Orme C, Rudolph A, Rumfola L, Schifitto G, Shinaman A, Sulimowicz K, Watts A, Eapen S, Zhang L, The Huntington Study Group (2001) A randomized, placebocontrolled trial of coenzyme Q(10) and remacemide in Huntington\u2019s disease. Neurology 57: 397\u2013404",
      "journal-title": "Neurology"
    },
    {
      "key": "14_CR11",
      "doi-asserted-by": "publisher",
      "first-page": "1000",
      "DOI": "10.1212/WNL.53.5.1000",
      "volume": "53",
      "author": "B Kremer",
      "year": "1999",
      "unstructured": "Kremer B, Clark CM, Almqvist EW, Raymond LA, Graf P, Jacova C, Mezei M, Hardy MA, Snow B, Martin W, Hayden MR (1999) Influence of lamotrigine on progression of early Huntington disease \u2014 a randomized clinical trial. Neurology 53: 1000\u20131011",
      "journal-title": "Neurology"
    },
    {
      "key": "14_CR12",
      "first-page": "923",
      "volume": "75",
      "author": "H Lange",
      "year": "1983",
      "unstructured": "Lange HW (1983) Quantitative changes of telencephalon, diencephalon and mesencephalon in Huntington\u2019s chorea, postencephalitic and idiopathic parkinsonism. Verh Anat Ges 75: 923\u2013925",
      "journal-title": "Verh Anat Ges"
    },
    {
      "key": "14_CR13",
      "volume-title": "Kurztest f\u00fcr allgemein e Intelligenz KA",
      "author": "S Lehrl",
      "year": "1980",
      "unstructured": "Lehrl S, Gallwitz A, Blaha L, Fischer B (1980) Kurztest f\u00fcr allgemein e Intelligenz KAI. VLESS Vaterstetten"
    },
    {
      "key": "14_CR14",
      "doi-asserted-by": "publisher",
      "first-page": "638",
      "DOI": "10.1016/S0959-4388(96)80097-3",
      "volume": "6",
      "author": "ME MacDonald",
      "year": "1996",
      "unstructured": "MacDonald ME, Gusella JF (1996) Huntington\u2019s disease: translating a CAG repeat into a pathogenic mechanism. Cuff Opin Neurobiol 6: 638\u2013643",
      "journal-title": "Cuff Opin Neurobiol"
    },
    {
      "key": "14_CR15",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "DOI": "10.1212/WNL.49.1.153",
      "volume": "49",
      "author": "DL Murman",
      "year": "1997",
      "unstructured": "Murman DL, Giordani B, Mellow AM, Johanns JR, Little RJA, Hariharan M, Foster NL (1997) Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington\u2019s disease. Neurology 49: 153\u2013161",
      "journal-title": "Neurology"
    },
    {
      "key": "14_CR16",
      "doi-asserted-by": "publisher",
      "first-page": "735",
      "DOI": "10.1016/S0028-3908(99)00019-2",
      "volume": "138",
      "author": "CG Parsons",
      "year": "1999",
      "unstructured": "Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated NMDA receptor antagonist-a review of preclinical data. Neuropharmacology 138: 735\u2013767",
      "journal-title": "Neuropharmacology"
    },
    {
      "key": "14_CR17",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "DOI": "10.1002/ana.410330414",
      "volume": "33",
      "author": "JW Pellegrini",
      "year": "1993",
      "unstructured": "Pellegrini JW, Lipton SA (1993) Delayed administration of memantine prevents N-methyl-Daspartate receptor mediated neurotoxicity. Ann Neurol 33: 403\u2013407",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "14_CR18",
      "unstructured": "Raitan RM (1956) Trail Making Test. Manual for administration, scoring and interpolation. Indiana University Press Indianapolis"
    },
    {
      "key": "14_CR19",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "DOI": "10.1212/WNL.29.1.1",
      "volume": "29",
      "author": "I Shoulson",
      "year": "1979",
      "unstructured": "Shoulson I, Fahn S (1979) Huntington disease; clinical care and evaluation. Neurology 29: 1\u20133",
      "journal-title": "Neurology"
    }
  ],
  "container-title": "Journal of Neural Transmission. Supplementa",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/978-3-7091-0579-5_14",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        16
      ]
    ],
    "date-time": "2019-05-16T04:25:40Z",
    "timestamp": 1557980740000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/978-3-7091-0579-5_14"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2004
      ]
    ]
  },
  "ISBN": [
    "9783211211144",
    "9783709105795"
  ],
  "references-count": 19,
  "URL": "http://dx.doi.org/10.1007/978-3-7091-0579-5_14",
  "relation": {},
  "ISSN": [
    "0303-6995"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2004
      ]
    ]
  }
}